This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Holocarboxylase Synthetase Deficiency
Information about Holocarboxylase Synthetase Deficiency: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Holocarboxylase Synthetase Deficiency
Most recent studies have shown that Holocarboxylase Synthetase Deficiency shares some biological mechanisms with acidemia, acidosis, acidosis-lactic, biotin-deficiency, biotinidase-deficiency, dermatitis, exanthema, hyperammonemia, inborn-errors-of-metabolism, macular-corneal-dystrophy-type-i, metabolic-acidosis, metabolic-diseases, methylmalonic-acidemia, multiple-carboxylase-deficiency, propionic-acidemia, pyruvate-carboxylase-deficiency-disease, vomiting.
Among the many pathways, these few ones have gauged particular interests from scientists studying Holocarboxylase Synthetase Deficiency, and have been seen in publications frequently: Biotin Transport, Cellular Homeostasis, Excretion, Fatty Acid Oxidation, Gluconeogenesis, Histone Biotinylation, Methylation, Pathogenesis, Proteolysis, Regulation Of Gene Expression, Response To Biotin, Transport
Quite a number of genes have been found to play important roles in Holocarboxylase Synthetase Deficiency, such as ACAA2, BTD, CD80, CSF2, CYCS, CYP17A1, DNMT1, ECHDC1, HLCS, KIT, LAMC2, MECP2, MLYCD, MTSS1, PC, QPCT, SLC22A5, SLC25A13, SP8. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.